| abstract |
humanized antibody 244, bispecific antibody or antigen binding fragments thereof, pharmaceutical composition, kit and use of said antibodies. The present invention relates to humanized antibodies that specifically bind hla-dr. antibodies recognize the epitope recognized by mouse monoclonal antibody 243. Methods are provided for the preparation of such antibodies, pharmaceutical compositions containing such antibodies, and clinical diagnostic and therapeutic, as well as screening related uses for such antibodies. |